Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Protein synthesis inhibitor, used to measure pr...
5-Nitroimidazole derivative; genotoxic.
FLT3, PDGFR inhibitor.
Mycotoxin that has structural similarity to est...
Indole, glucosinolate found in cruciferous vege...
PI3K inhibitor.
Nitroimidazole; hypoxic modifier and radiosensi...
NO donor; AR antagonist.
Mycotoxin produced by Alternaria; topoisomerase...
Tyrosine kinase inhibitor.
Polyphenolic compound present in black tea.
5-Lipoxygenase inhibitor.
GSK-3 inhibitor.
Selective inhibitor of LRRK2.
Polyphenol found in species of Solanum and Magn...
p110α PI3K inhibitor.
Derivative of methyl caffeate, hydroxycinnamic ...
Endogenous peptide involved in vascular contrac...
Kynurenine 3-hydroxylase inhibitor.
Prodrug of the compound mycophenolic acid.